ANGO vs CBRE · rev $292.5M vs P/E 43, rev $35.77B
AngioDynamics Inc (ANGO) versus CBRE Group Inc Class A (CBRE) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
ANGO currently screens at market cap $378.5M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Not investment advice. Open the ANGO and CBRE stock pages for the full models.
Not investment advice.